Alaleh Nouri Biography and Net Worth

Ms. Nouri has served as our EVP, Chief Legal Officer & Corporate Secretary since January 2022. She has also served as our Chief Compliance Officer since September 2018. She previously served as our SVP, General Counsel & Corporate Secretary from July 2018 until December 2021. Prior to joining PROCEPT BioRobotics, Ms. Nouri served as Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer at Accuray Inc., a radiation oncology company, from February 2014 to July 2018. In her more than 15-year legal career in private practice law firms and with corporations as in-house counsel, Ms. Nouri has advised on corporate, transactional, and regulatory compliance matters including corporate governance, strategic transactions, mergers and acquisitions, intellectual property portfolio management, public disclosure issues, and SEC reporting and compliance. Ms. Nouri received a J.D. from U.C. College of the Law, San Francisco (formerly U.C. Hastings College of Law) and a Bachelor of Commerce in International Business and also completed the requirements for a finance specialization from the University of British Columbia.

What is Alaleh Nouri's net worth?: The estimated net worth of Alaleh Nouri is at least $2.44 million as of March 19th, 2026. Ms. Nouri owns 105,354 shares of PROCEPT BioRobotics stock worth more than $2,444,213 as of April 11th. This net worth approximation does not reflect any other assets that Ms. Nouri may own. Learn More about Alaleh Nouri's net worth.
How do I contact Alaleh Nouri?: The corporate mailing address for Ms. Nouri and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Alaleh Nouri's contact information.
Has Alaleh Nouri been buying or selling shares of PROCEPT BioRobotics?: Alaleh Nouri has not been actively trading shares of PROCEPT BioRobotics over the course of the past ninety days. Most recently, Alaleh Nouri sold 5,363 shares of the business's stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $25.96, for a transaction totalling $139,223.48. Following the completion of the sale, the executive vice president now directly owns 105,354 shares of the company's stock, valued at $2,734,989.84. Learn More on Alaleh Nouri's trading history.
Who are PROCEPT BioRobotics' active insiders?: PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Alaleh Nouri (EVP), Hisham Shiblaq (EVP, Chief Commercial Officer), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.
Are insiders buying or selling shares of PROCEPT BioRobotics?: In the last twelve months, PROCEPT BioRobotics insiders bought shares 3 times. They purchased a total of 426,262 shares worth more than $10,483,091.16. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 123,229 shares worth more than $6,844,716.03. The most recent insider tranaction occured on March, 19th when EVP Alaleh Nouri sold 5,363 shares worth more than $139,223.48. Insiders at PROCEPT BioRobotics own 6.6% of the company. Learn More about insider trades at PROCEPT BioRobotics.
Information on this page was last updated on 3/19/2026.

Alaleh Nouri Insider Trading History at PROCEPT BioRobotics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/19/2026	Sell	5,363	$25.96	$139,223.48	105,354
3/17/2026	Sell	304	$28.15	$8,557.60	110,717
3/10/2026	Sell	3,243	$25.65	$83,182.95	111,021
3/6/2026	Sell	6,892	$23.70	$163,340.40	114,264
12/4/2024	Sell	28,092	$97.13	$2,728,575.96	52,472
6/17/2024	Sell	10,000	$62.18	$621,800.00	52,472
5/3/2024	Sell	30,432	$62.97	$1,916,303.04	62,472
3/18/2024	Sell	441	$48.83	$21,534.03	62,472
3/6/2024	Sell	2,749	$46.67	$128,295.83	62,913
2/9/2024	Sell	14,694	$49.97	$734,259.18	47,351
2/7/2024	Sell	5,306	$49.95	$265,034.70	47,351
1/9/2024	Sell	16,000	$44.97	$719,520.00	47,351
12/14/2023	Sell	3,204	$42.95	$137,611.80	46,933
12/6/2023	Sell	6,096	$39.96	$243,596.16	46,933
7/27/2023	Sell	7,903	$40.00	$316,120.00	46,933
12/27/2022	Sell	3,064	$40.90	$125,317.60	4,062
12/19/2022	Sell	20,000	$43.23	$864,600.00	7,126
12/16/2022	Sell	20,000	$41.97	$839,400.00	27,126
5/16/2022	Sell	678	$35.06	$23,770.68	46,468

Alaleh Nouri Buying and Selling Activity at PROCEPT BioRobotics

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Today's Range

Now: $23.20

$22.81

$23.80

50 Day Range

MA: $26.32

$22.69

$29.95

2 Week Range

Now: $23.20

$19.35

$66.85

Volume

1,129,775 shs

Average Volume

1,256,558 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94